Capricor Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CAPR Nasdaq 2830 www.capricor.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Capricor Therapeutics, Inc.

Sector Update: Healthcare Stocks Gain Late Afternoon - Sep 14th, 2026 1:59 pm
3 Small-Cap Biotechs With Binary Catalysts on the Calendar - Sep 13th, 2026 8:50 am
CAPR Stock Skyrockets 144% in a Month: What Is Driving the Rally? - Sep 7th, 2026 7:28 am
Could New Long-Term Data Support Capricor’s Duchenne Therapy? - Sep 4th, 2026 6:44 pm
Sector Update: Healthcare Stocks Advance Late Afternoon - Sep 1st, 2026 1:46 pm
Capricor Therapeutics shares rise 2.5% following August FDA update - Sep 1st, 2026 4:55 am
Why Is CAPR Stock Rising Today? Piper Sandler Says Risk-Reward Favors Owning Stock Into FDA Decision - Sep 1st, 2026 4:52 am
SRPT On Track For Best Week In 5 Months Ahead Of Late-2026 Clinical Data — Retail Eyes ‘Monumental Comeback’ - Aug 27th, 2026 1:00 pm
A Rejected Vote Pushes Capricor (CAPR) Toward A Narrower Path - Aug 27th, 2026 8:25 am
CAPR Stock Climbs On FDA’s Three-Month Deramiocel Extension — HC Wainwright Sticks To Neutral, Flags High Rejection Risk - Aug 24th, 2026 3:02 pm
Sector Update: Healthcare Stocks Softer Late Afternoon - Aug 24th, 2026 1:47 pm
Sector Update: Healthcare Stocks Decline in Afternoon Trading - Aug 24th, 2026 11:50 am
Why Is CAPR Stock Rising Today? - Aug 24th, 2026 8:33 am
Capricor Therapeutics Deramiocel PDUFA Date Extended to November as FDA Reviews BLA Amendment - Aug 24th, 2026 8:05 am
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA - Aug 24th, 2026 7:25 am
FDA extends review of Capricor cell therapy; Pain drug startup to go public - Aug 24th, 2026 5:30 am
CAPR Stock Sinks As Investors Brace For Imminent FDA Call On Deramiocel - Aug 21st, 2026 4:48 pm
Capricor Draws Investor Attention As Shareholder Kaos Capital Pushes For Board Shakeup Ahead Of Key FDA Decision On DMD Therapy - Aug 21st, 2026 9:00 am
Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders - Aug 21st, 2026 5:45 am